CASI PHARMACEUTICALS, INC. Debt Securities, Realized Gain (Loss)
CASI PHARMACEUTICALS, INC. (CASIF) reported Debt Securities, Realized Gain (Loss) of $474.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesRealizedGainLoss · last filed 2026-05-15
| Period end | Debt Securities, Realized Gain (Loss) 12 month |
|---|---|
| 2023-12-31 | $474.00K 20-F · filed 2026-05-15 |